Overview

LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to compare the efficacy of treatment with LEO 90100 to that of treatment with vehicle for up to 4 weeks in subjects with psoriasis vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma